VALENTINE ANYIAM: Open Payments
NPI 1730683194 · THE VILLAGES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,068 in 52 payments from 8 companies in 2025. Trend: 2023 $689 · 2024 $1,473 · 2025 $2,068
Food & beverage: $2,068
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $611 |
| Axsome Therapeutics, Inc. | 13 | $436 |
| Neurocrine BioSciences, Inc. | 7 | $357 |
| ABBVIE INC. | 9 | $314 |
| Collegium Pharmaceutical, Inc. | 2 | $129 |
| E.R. Squibb & Sons, L.L.C. | 1 | $128 |
| Tris Pharma Inc | 3 | $71 |
| Alkermes, Inc. | 1 | $21 |
Products named: CAPLYTA, Auvelity, INGREZZA, VRAYLAR, Jornay PM, COBENFY, Dyanavel XR, LYBALVI.
Industry payments across FL — which companies pay providers there.
